Premium
Brain‐derived neurotrophic factor as a potential biomarker of chemotherapy‐induced peripheral neuropathy and prognosis in haematological malignancies; what we have learned, the challenges and a need for global standardization
Author(s) -
Azoulay David,
Horowitz Netanel A.
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16893
Subject(s) - medicine , neurotrophic factors , peripheral neuropathy , biomarker , brain derived neurotrophic factor , multiple myeloma , peripheral blood mononuclear cell , neurotrophin , oncology , bone marrow , chemotherapy induced peripheral neuropathy , chemotherapy , cancer , hematology , immunology , endocrinology , biology , receptor , diabetes mellitus , biochemistry , in vitro